MedPath

Meta-analysis of Stannous Fluoride and the Effects on Gingival Health

Completed
Conditions
Gingivitis
Interventions
Drug: Positive control dentifrice
Drug: Negative control dentifrice
Drug: Stannous Fluoride Dentifrice
Registration Number
NCT03970759
Lead Sponsor
Procter and Gamble
Brief Summary

The aim of this 18 study analysis was to compare the effect of bioavailable stannous fluoride (SnF2) dentifrices when used up to 3 months on gingivitis relative to a positive or negative control dentifrice.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
2890
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
Positive Control DentifricePositive control dentifriceTwice daily brushing
Negative Control DentifriceNegative control dentifriceTwice daily brushing
Stannous Fluoride DentifriceStannous Fluoride DentifriceTwice daily brushing
Primary Outcome Measures
NameTimeMethod
Number of Bleeding SitesUp to 12 Weeks

Change from baseline as measured on number of bleeding sites (gingival bleeding index or Loe Silness index).

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Multiple P&G Investigation Clinical Sites

🇺🇸

Cincinnati, Ohio, United States

© Copyright 2025. All Rights Reserved by MedPath